News

Darcey Black, Translational Director at TherapeutAix, will be co-organising and attending the ‘Innovative New Pharma and Biotech Partnerships: How is…

Non-alcoholic steatohepatitis, or NASH, remains a disease with no approved therapeutics. And it’s been a tough area for drug development,…

TherapeutAix will be attending the 20th Fraunhofer Seminar ‘Models of Lung Disease’ on 22-24 June at the CRC Hannover in…

TherapeutAix is attending and presenting at the Extracellular Matrix Pharmacology Congress 2022, on 23-25 June at the Tivoli Congress Centre…

ELRIG’s annual Drug Discovery meeting is returning this October, giving us an excellent chance to re-connect with colleagues and discuss…

TherapeutAix’ Director of Project Strategy, Bob Humphries, will be chairing the British Pharmacological Society workshop “Pharmacology & Drug Discovery” on…

Darcey Black and Simon Cruwys will be running the Outsourcing Workshop at this year’s BOS Virtual.  Biotech Outsourcing Strategies is an established…

TherapeutAix will be taking part in the Society for Medicines Research (SMR) Meeting on “Innovative Early Clinical Trial Designs and…

TherapeutAix is attending the Extracellular Matrix Pharmacology Symposium hosted by network partner Nordic Bioscience on March 24th – 25th.   The online symposium will centre on…

As 2020 draws to a close, the team at TheraeutAix has been looking back and reflecting on the last 12…